Tissue-engineered lymphatic graft for the treatment of lymphedema.
Identifieur interne : 001300 ( PubMed/Corpus ); précédent : 001299; suivant : 001301Tissue-engineered lymphatic graft for the treatment of lymphedema.
Auteurs : Muholan Kanapathy ; Nikhil M. Patel ; Deepak M. Kalaskar ; Afshin Mosahebi ; Babak J. Mehrara ; Alexander M. SeifalianSource :
- The Journal of surgical research [ 1095-8673 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- methods : Nanotechnology, Tissue Engineering.
- physiology : Lymphatic Vessels.
- surgery : Lymphedema.
- therapy : Lymphedema.
- transplantation : Lymphatic Vessels.
- Humans, Regeneration.
Abstract
Lymphedema is a chronic debilitating condition and curative treatment is yet to be found. Tissue engineering approach, which combines cellular components, scaffold, and molecular signals hold great potential in the treatment of secondary lymphedema with the advent of lymphatic graft to reconstruct damaged collecting lymphatic vessel. This review highlights the ideal characteristics of lymphatic graft, the limitation and challenges faced, and the approaches in developing tissue-engineered lymphatic graft.
DOI: 10.1016/j.jss.2014.07.059
PubMed: 25248852
Links to Exploration step
pubmed:25248852Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Tissue-engineered lymphatic graft for the treatment of lymphedema.</title><author><name sortKey="Kanapathy, Muholan" sort="Kanapathy, Muholan" uniqKey="Kanapathy M" first="Muholan" last="Kanapathy">Muholan Kanapathy</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Patel, Nikhil M" sort="Patel, Nikhil M" uniqKey="Patel N" first="Nikhil M" last="Patel">Nikhil M. Patel</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Kalaskar, Deepak M" sort="Kalaskar, Deepak M" uniqKey="Kalaskar D" first="Deepak M" last="Kalaskar">Deepak M. Kalaskar</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Mosahebi, Afshin" sort="Mosahebi, Afshin" uniqKey="Mosahebi A" first="Afshin" last="Mosahebi">Afshin Mosahebi</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom; Department of Plastic and Reconstructive Surgery, Royal Free London NHS Foundation Trust Hospital, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J" last="Mehrara">Babak J. Mehrara</name><affiliation><nlm:affiliation>Department of Plastic and Reconstructive Surgery, Memorial Sloan-Kettering Cancer Centre, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Seifalian, Alexander M" sort="Seifalian, Alexander M" uniqKey="Seifalian A" first="Alexander M" last="Seifalian">Alexander M. Seifalian</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom. Electronic address: a.seifalian@ucl.ac.uk.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25248852</idno><idno type="pmid">25248852</idno><idno type="doi">10.1016/j.jss.2014.07.059</idno><idno type="wicri:Area/PubMed/Corpus">001300</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001300</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Tissue-engineered lymphatic graft for the treatment of lymphedema.</title><author><name sortKey="Kanapathy, Muholan" sort="Kanapathy, Muholan" uniqKey="Kanapathy M" first="Muholan" last="Kanapathy">Muholan Kanapathy</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Patel, Nikhil M" sort="Patel, Nikhil M" uniqKey="Patel N" first="Nikhil M" last="Patel">Nikhil M. Patel</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Kalaskar, Deepak M" sort="Kalaskar, Deepak M" uniqKey="Kalaskar D" first="Deepak M" last="Kalaskar">Deepak M. Kalaskar</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Mosahebi, Afshin" sort="Mosahebi, Afshin" uniqKey="Mosahebi A" first="Afshin" last="Mosahebi">Afshin Mosahebi</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom; Department of Plastic and Reconstructive Surgery, Royal Free London NHS Foundation Trust Hospital, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Mehrara, Babak J" sort="Mehrara, Babak J" uniqKey="Mehrara B" first="Babak J" last="Mehrara">Babak J. Mehrara</name><affiliation><nlm:affiliation>Department of Plastic and Reconstructive Surgery, Memorial Sloan-Kettering Cancer Centre, New York.</nlm:affiliation></affiliation></author><author><name sortKey="Seifalian, Alexander M" sort="Seifalian, Alexander M" uniqKey="Seifalian A" first="Alexander M" last="Seifalian">Alexander M. Seifalian</name><affiliation><nlm:affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom. Electronic address: a.seifalian@ucl.ac.uk.</nlm:affiliation></affiliation></author></analytic><series><title level="j">The Journal of surgical research</title><idno type="eISSN">1095-8673</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term><term>Lymphatic Vessels (physiology)</term><term>Lymphatic Vessels (transplantation)</term><term>Lymphedema (surgery)</term><term>Lymphedema (therapy)</term><term>Nanotechnology (methods)</term><term>Regeneration</term><term>Tissue Engineering (methods)</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Nanotechnology</term><term>Tissue Engineering</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Lymphatic Vessels</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="transplantation" xml:lang="en"><term>Lymphatic Vessels</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Regeneration</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphedema is a chronic debilitating condition and curative treatment is yet to be found. Tissue engineering approach, which combines cellular components, scaffold, and molecular signals hold great potential in the treatment of secondary lymphedema with the advent of lymphatic graft to reconstruct damaged collecting lymphatic vessel. This review highlights the ideal characteristics of lymphatic graft, the limitation and challenges faced, and the approaches in developing tissue-engineered lymphatic graft.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25248852</PMID><DateCreated><Year>2014</Year><Month>12</Month><Day>03</Day></DateCreated><DateCompleted><Year>2015</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>192</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J. Surg. Res.</ISOAbbreviation></Journal><ArticleTitle>Tissue-engineered lymphatic graft for the treatment of lymphedema.</ArticleTitle><Pagination><MedlinePgn>544-54</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2014.07.059</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(14)00723-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lymphedema is a chronic debilitating condition and curative treatment is yet to be found. Tissue engineering approach, which combines cellular components, scaffold, and molecular signals hold great potential in the treatment of secondary lymphedema with the advent of lymphatic graft to reconstruct damaged collecting lymphatic vessel. This review highlights the ideal characteristics of lymphatic graft, the limitation and challenges faced, and the approaches in developing tissue-engineered lymphatic graft.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature on tissue engineering of lymphatic system and lymphatic tissue biology was reviewed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prime challenge in the design and manufacturing of this graft is producing endothelialized conduit with intraluminal valves. Suitable scaffold material is needed to ensure stability and functionality of the construct. Endothelialization of the construct can be enhanced via biofunctionalization and nanotopography, which mimics extracellular matrix. Nanocomposite polymers with improved performance over existing biomaterials are likely to benefit the development of lymphatic graft.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">With the in-depth understanding of tissue engineering, nanotechnology, and improved knowledge on the biology of lymphatic regeneration, the aspiration to develop successful lymphatic graft is well achievable.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kanapathy</LastName><ForeName>Muholan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Nikhil M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalaskar</LastName><ForeName>Deepak M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosahebi</LastName><ForeName>Afshin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom; Department of Plastic and Reconstructive Surgery, Royal Free London NHS Foundation Trust Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrara</LastName><ForeName>Babak J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, Memorial Sloan-Kettering Cancer Centre, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seifalian</LastName><ForeName>Alexander M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Division of Surgery & Interventional Science, UCL Centre for Nanotechnology & Regenerative Medicine, University College London, London, United Kingdom. Electronic address: a.seifalian@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL111130</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Hypertension. 2004 Aug;44(2):203-9</RefSource><PMID Version="1">15238569</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2003 Mar;111(5):717-25</RefSource><PMID Version="1">12618526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Physiol. 2010 Oct 15;588(Pt 20):3957-69</RefSource><PMID Version="1">20724369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2003;1(1):25-9; discussion 29-31</RefSource><PMID Version="1">15624318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2012 Dec;10(4):152-63</RefSource><PMID Version="1">23145980</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vasc Res. 2000 Jan-Feb;37(1):61-7</RefSource><PMID Version="1">10720887</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2013;2013:804675</RefSource><PMID Version="1">24222916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol Przegl Chir. 1967 Sep;39(9):926-9</RefSource><PMID Version="1">6063781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biotechnol. 2010 Oct 1;150(1):182-9</RefSource><PMID Version="1">20691226</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2010 Mar 19;106(5):920-31</RefSource><PMID Version="1">20133901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2007 Apr;117(4):997-1007</RefSource><PMID Version="1">17364025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2008 Apr;121(4):1144-52</RefSource><PMID Version="1">18349631</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2011 May;127(5):1979-86</RefSource><PMID Version="1">21532424</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2013;2013:208912</RefSource><PMID Version="1">24350251</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vascul Pharmacol. 2008 Jul;49(1):44-50</RefSource><PMID Version="1">18571474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2009 Aug;17(2):175-86</RefSource><PMID Version="1">19686679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microcirculation. 2004 Sep;11(6):477-92</RefSource><PMID Version="1">15371129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2004 Jan;25(1):53-61</RefSource><PMID Version="1">14580908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2007 Apr;21(4):1003-12</RefSource><PMID Version="1">17210781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomech. 1999 Dec;32(12):1297-307</RefSource><PMID Version="1">10569708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomed Opt. 2012 Aug;17(8):086005</RefSource><PMID Version="1">23224192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2008 Aug;28(15):4843-50</RefSource><PMID Version="1">18519586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2010 Sep 15;70(18):7053-62</RefSource><PMID Version="1">20823159</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Med Genet. 2002 Jul;39(7):478-83</RefSource><PMID Version="1">12114478</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2009;7(2):87-96</RefSource><PMID Version="1">19534632</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Biol. 2006 Jun 15;294(2):458-70</RefSource><PMID Version="1">16678147</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Feb 10;23(5):1011-27</RefSource><PMID Version="1">15585754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Dec 15;438(7070):946-53</RefSource><PMID Version="1">16355212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 May;14(6):500-15</RefSource><PMID Version="1">23540561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2002 Oct;129(20):4797-806</RefSource><PMID Version="1">12361971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2003 Apr 18;92(7):801-8</RefSource><PMID Version="1">12623882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microvasc Res. 2006 Nov;72(3):161-71</RefSource><PMID Version="1">16876204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Z Zellforsch Mikrosk Anat. 1973;143(2):149-68</RefSource><PMID Version="1">4761509</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Vasc Endovasc Surg. 2008 Aug;36(2):230-6</RefSource><PMID Version="1">18534875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Mater Eng. 2009;19(4-5):317-31</RefSource><PMID Version="1">20042799</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vasc Surg. 2004 Jul;40(1):146-53</RefSource><PMID Version="1">15218475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2011;9(3):159-67</RefSource><PMID Version="1">22066746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2012 Feb 14;22(2):430-45</RefSource><PMID Version="1">22306086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2003 Jul 15;22(14):3546-56</RefSource><PMID Version="1">12853470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2008 Jun;28(12):4026-39</RefSource><PMID Version="1">18411305</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mech Behav Biomed Mater. 2012 Apr;8:58-70</RefSource><PMID Version="1">22402154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 1990 Jan;85(1):64-74; discussion 75-6</RefSource><PMID Version="1">2293739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2005 Mar;25(6):2441-9</RefSource><PMID Version="1">15743836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomater Appl. 2001 Jan;15(3):241-78</RefSource><PMID Version="1">11261602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2008 Jan;118(1):40-50</RefSource><PMID Version="1">18097475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2003 Jan 10;299(5604):247-51</RefSource><PMID Version="1">12522250</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nanomedicine. 2014 Feb;10(2):279-89</RefSource><PMID Version="1">24008020</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2010 Mar;176(3):1122-9</RefSource><PMID Version="1">20110415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Cells. 2009 Mar;14(3):425-34</RefSource><PMID Version="1">19210544</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2010 Dec;177(6):3202-14</RefSource><PMID Version="1">21056998</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Prog. 2010 May-Jun;26(3):819-26</RefSource><PMID Version="1">20039440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol. 1980 Jul;239(1):H88-95</RefSource><PMID Version="1">7396023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mech Dev. 2009 May-Jun;126(5-6):350-65</RefSource><PMID Version="1">19233265</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acc Chem Res. 2005 Nov;38(11):879-84</RefSource><PMID Version="1">16285710</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2006;4(4):191-8</RefSource><PMID Version="1">17394402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Cardiovasc Ther. 2008 Oct;6(9):1259-77</RefSource><PMID Version="1">18939913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2008 Dec 1;80(3):339-45</RefSource><PMID Version="1">18708640</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Tissue Eng. 2006 Aug;12(8):2355-65</RefSource><PMID Version="1">16968175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Future Oncol. 2011 Dec;7(12):1457-73</RefSource><PMID Version="1">22112321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Ther. 2005 Jul;12(1):58-67</RefSource><PMID Version="1">15963921</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2006 Jul;27(19):3675-83</RefSource><PMID Version="1">16519932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol. 1980 Dec;239(6):H775-83</RefSource><PMID Version="1">7446752</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cell Biochem Biophys. 2006;45(2):129-36</RefSource><PMID Version="1">16757813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microsurgery. 1983;4(4):236-42</RefSource><PMID Version="1">6669022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2070-6</RefSource><PMID Version="1">16690875</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Development. 2009 Jan;136(2):191-5</RefSource><PMID Version="1">19056831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Cell. 2005 Feb;7(2):121-7</RefSource><PMID Version="1">15710325</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>FASEB J. 2008 Jun;22(6):2084-9</RefSource><PMID Version="1">18203957</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Bioeng. 2007 Jan 1;96(1):167-76</RefSource><PMID Version="1">17133613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Biomed Eng. 2014 Aug;42(8):1691-704</RefSource><PMID Version="1">24809724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2009 Jan 20;119(2):281-9</RefSource><PMID Version="1">19118255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomed Mater Res A. 2009 Feb;88(2):419-26</RefSource><PMID Version="1">18306321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2003 Sep;36(3):111-9</RefSource><PMID Version="1">14552030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Physiol. 2006 Jan 1;570(Pt 1):23-8</RefSource><PMID Version="1">16239271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2001 Feb;7(2):199-205</RefSource><PMID Version="1">11175851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Res. 2005 Jun 10;96(11):1193-9</RefSource><PMID Version="1">15890974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2006 Sep;11(3):349-61</RefSource><PMID Version="1">16950126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2008 Dec 4;456(7222):643-7</RefSource><PMID Version="1">18931657</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomaterials. 2006 Mar;27(9):1971-9</RefSource><PMID Version="1">16253324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cell Biol. 2007 Jan;17(1):44-50</RefSource><PMID Version="1">17141502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2008 Dec 1;22(23):3282-91</RefSource><PMID Version="1">19056883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2003 Feb;162(2):575-86</RefSource><PMID Version="1">12547715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microvasc Res. 2004 Nov;68(3):258-64</RefSource><PMID Version="1">15501245</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Future Oncol. 2013 Sep;9(9):1365-74</RefSource><PMID Version="1">23980683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cell Biol. 2012;2012:853703</RefSource><PMID Version="1">22505936</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Biol. 2007 Jun;27(12):4541-50</RefSource><PMID Version="1">17438136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biotechnol Appl Biochem. 2009 Jan;52(Pt 1):1-8</RefSource><PMID Version="1">18402554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2000 Feb;190(3):292-9</RefSource><PMID Version="1">10685063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Eng Technol. 2011 Dec;2(4):296-308</RefSource><PMID Version="1">23408477</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Vasc Res. 2009;46(5):426-34</RefSource><PMID Version="1">19155634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2008;1131:100-9</RefSource><PMID Version="1">18519963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dev Cell. 2002 Sep;3(3):411-23</RefSource><PMID Version="1">12361603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2006 Sep 12;114(11):1177-84</RefSource><PMID Version="1">16952986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microsurgery. 2001;21(4):143-7</RefSource><PMID Version="1">11494381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2002 Dec;979:197-210; discussion 229-34</RefSource><PMID Version="1">12543729</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cell Physiol. 2009 May;219(2):430-7</RefSource><PMID Version="1">19170073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Drug Deliv Rev. 2000 Aug 20;42(1-2):139-61</RefSource><PMID Version="1">10942819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2008;1131:44-9</RefSource><PMID Version="1">18519958</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Genes Dev. 2005 Feb 1;19(3):397-410</RefSource><PMID Version="1">15687262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Genet. 2009 Apr;41(4):396-8</RefSource><PMID Version="1">19287381</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Histochem Cell Biol. 2008 Dec;130(6):1063-78</RefSource><PMID Version="1">18946678</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2001 Sep 17;194(6):797-808</RefSource><PMID Version="1">11560995</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042601" MajorTopicYN="N">Lymphatic Vessels</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000637" MajorTopicYN="Y">transplantation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036103" MajorTopicYN="N">Nanotechnology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012038" MajorTopicYN="Y">Regeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023822" MajorTopicYN="N">Tissue Engineering</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">NIHMS678316</OtherID><OtherID Source="NLM">PMC4394124</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lymphatic graft</Keyword><Keyword MajorTopicYN="N">Lymphatic regeneration</Keyword><Keyword MajorTopicYN="N">Lymphedema</Keyword><Keyword MajorTopicYN="N">Nanotechnology</Keyword><Keyword MajorTopicYN="N">Tissue engineering</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>05</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>07</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25248852</ArticleId><ArticleId IdType="pii">S0022-4804(14)00723-9</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2014.07.059</ArticleId><ArticleId IdType="pmc">PMC4394124</ArticleId><ArticleId IdType="mid">NIHMS678316</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001300 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001300 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25248852
|texte= Tissue-engineered lymphatic graft for the treatment of lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25248852" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |